Form 8-K FATE THERAPEUTICS INC For: Aug 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140812/AVAYBG2C8Z22VZZZ2RJR2ZZZGSASZ2Z2Z262
Filed on: August 12, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fate Therapeutics shares Phase 1 FT819 data for lupus nephritis
- Bitcoin Price Prediction: $110 Million ETF Comeback Meets the $80,000 Wall as AlphaPepe Brings Live AI Tools to the Presale Fight
- Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
